Co-morbidity of Diabetes and Tuberculosis Can Affect the Results of Treatment; A Case Control Study in Iran

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 64

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JHES-10-3_003

تاریخ نمایه سازی: 8 آذر 1402

Abstract:

Background and Purpose: Several evidences have shown some synergistic effect of diabetes co-morbidity on the tuberculosis (TB) treatment results, while some other studies have not found such associations. This study aimed to investigate the relationship between TB-diabetes co-morbidity and outcomes of TB treatment. Materials and Methods: The research population in this case control study were patients with smear positive tuberculosis. The cases were ۱۵۸ patients with TB and diabetes selected by consensus method, while controls were ۳۱۶ patients randomly selected from TB patients without diabetes. Results: Frequency of unfavorable outcome among cases was higher than among controls (۷.۶% vs ۷.۳% respectively, p-value =۰.۹۰۱). Multivariate logistic regression models showed that the odds ratios for adverse treatment outcome, death, treatment failure, positive smear after the intensive phase of treatment and high grade positivity (۲+ & ۳+) were ۰.۹۷(۰.۴۵- ۲.۰۶), ۰.۹۷(۰.۴۲-۲.۲۴), ۰.۹۱(۰.۱۷-۴.۸۵), ۱.۳۹(۰.۷۹- ۲.۴۴) and ۲.۵۷(۰.۸۳- ۷.۹۲) respectively. Moreover, treatment adverse outcomes among patients with drug complications (۲۲.۲% vs. ۶.۵%, p-value =۰.۰۱۰) and rural residents (۱۰% vs ۴.۹% respectively, p-value =۰.۰۳۷) were significantly higher than those among patients without complication and urban residents respectively. Conclusion: Although we did not observe any significant association between TB-diabetes co-morbidity and treatment results, there was a significant effect measure regarding the effect of smear positivity at the end of the intensive phase of treatment, especially high grade of smear positivity. Because of probable bias in the classification of the exposure, screening of TB patients regarding diabetes mellitus at the beginning of the treatment is recommended.

Authors

Mahdi Afshari

Pediatric Gastroenterology and Hepatology Research Center

Motahareh Kheradmand

Health Sciences Research Center, Addiction Institute

Mohsen Aarabi

Department of Family Medicine

Mohammadreza Parsaee

Health deputy

Fatemeh Roozbeh

Health deputy

Asghar Nezammahalleh

Health deputy

Keyvan Heydari

Student Research Committee, School of Medicine,

Maryam Zakian

Department of General Courses,

Mahmood Moosazadeh

Gastrointestinal Cancer Research Center, Non -communicable Diseases Institute

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of ...
  • Restrepo BI, Schlesinger LS. Impact of diabetes on the natural ...
  • Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur ...
  • Kumar Nathella P, Babu S. Influence of diabetes mellitus on ...
  • Shewade HD, Jeyashree K, Mahajan P, Kumar AMV. National guidelines ...
  • Workneh MH, Bjune GA, Yimer SA. Diabetes mellitus is associated ...
  • Jeon CY, Murray MB. Diabetes mellitus increases the risk of ...
  • Alebel A, Wondemagegn AT, Tesema C, Kibret GD, Wagnew F, ...
  • Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, ...
  • Sharma D, Goel NK, Sharma MK, Walia DK, Thakare MM, ...
  • Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, ...
  • KazempourDizaji M, Kazemnejad A, Tabarsi P, Zayeri F.Risk Factors Associated ...
  • NandakumarK V, Duraisamy K, Balakrishnan S, M S, S JS, ...
  • Martínez-Rodríguez A, Gonzalez-Díaz A, Armas L Sanchez L, Martínez-Morales MA, ...
  • Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. ...
  • Jumaev G, Tillashaykhov M, Muazzamov B, Radjabov B, Gadoev J, ...
  • Mukhtar F, Butt ZA. Risk ofadverse treatment outcomes among newpulmonary ...
  • Satung J, Kaewkungwal J, Silachamroon U, Pokaew P, Rattanajiamrangsree S, ...
  • Shahrezaei M, Maracy MR, Farid F. Factors affecting mortality and ...
  • Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ (۲۰۱۷) Association ...
  • Perez-Navarro LM, Fuentes-Dominguez FJ, Zenteno-Cuevas R. Type ۲ diabetes mellitus ...
  • Shariff NM, Safian N. Diabetes mellitus and its influence on ...
  • Viswanathan V, Vigneswari A, Selvan K, Satyavani K, Rajeswari R, ...
  • Adepoyibi T, Weigl B, Greb H, Neogi T, McGuire H. ...
  • نمایش کامل مراجع